Clinical Presentations

In this week’s set of Homerun Slides, we present the first of four parts on the issue of glycemic control in a hospital environment, a growing concern for clinicians at every level of care….

In this week’s set of Homerun Slides, we explore the question of why patients are so reluctant to monitor, and then provide you with some tools to help convince them of the importance of monitoring….

  In this week’s Homerun Slides set, we wrap up our series on Accountable Care Organizations with a discussion of both the benefits and limitations of these relatively new tools in healthcare management. Value-Based Purchasing (VBP) is also covered….

  In this week’s selection of Homerun Slides, we begin to delve into the details of what Accountable Care Organizations (ACOs) will mean for Medicare and Medicaid beneficiaries, and how the risk-sharing in these new model programs is handled….

  With the new year fast approaching and a raft of new rules coming into effect with the Affordable Healthcare Act, Accountable Care Organizations (ACOs) are suddenly in the news. What are they and what does all this mean for the medical profession? With this week’s Homerun Slides, we begun …

Starting and correcting multiple daily injections   This we have Part 4 of our Homerun Slides series on Starting Basal and Bolus Insulins, with topics covered including the different insulin pens available from Novo and Lilly, Starting MDI, and Correction Bolus Formula….

  In this week’s Homerun Slides, we continue our series on new insulins and insulin delivery systems, with topics covered including insulin therapy in type 2 diabetes, the advantages of starting with basal insulin in DM2, and an examination of a treatment to target study (NPH vs glargine)…

With last week’s news that the FDA’s Endocrinologic and Metabolic Drugs Advisory Committee has recommended the approval of degludec, we thought we’d give you an overview of this new drug’s pharmacology, the current approval status, trial results, and some of the cardiovascular safety concerns around degludec….

  In this week’s set of Homerun Slides, we continue with our exploration of new insulins with a brief overview of the different treatments for type 1 and type 2 diabetes as well as a comparison of human insulins and insulin analogues, and their timing and effectiveness. (This also ties …

  In this first set of Homerun Slides on the latest information on newer insulins and delivery systems, we review the state of diabetes in America, including current mortality rates for some diabetic complications…